Aktis Oncology, Inc.
AKTS
$20.34
$1.226.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -22.29% | -25.56% | |||
| Total Depreciation and Amortization | 34.71% | 57.60% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 502.75% | 163.70% | |||
| Change in Net Operating Assets | -283.66% | -110.05% | |||
| Cash from Operations | -38.67% | -19.08% | |||
| Capital Expenditure | 2.06% | -86.36% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -45.29% | 28.33% | |||
| Cash from Investing | -47.39% | 26.85% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 679,520.00% | 296.92% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -336.87% | 44.89% | |||
| Cash from Financing | 72,225.43% | 57.21% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 1,482.88% | 24.01% | |||